Sachs Associates would like to say we enjoyed hosting you at our 6th Annual Neuroscience Innovation Forum (NIF). We would like to thank those who joined us in-person in San Francisco and those who participated virtually last week. A special thank you goes to the excellent line up of sponsors, chairs, panelists and presenters who made such a broad and interesting programme possible.
The NIF has proven to be successful in supporting our community with 358 people from 23 countries registered and a busy meeting system.
We look forward to welcoming you again to our future events!
Exhibitors Included:
Neuroscience Trials Australia
Confirmed Keynote Speakers Included:
Charles Fisher
Founder & CEO, Unlearn.AI, Inc.
Harry Tracy
President, NI Research Inc.
Speakers and Chairs Included:
Beth Shafer
VP, Head of R&D BD, Gastroenterology, Neuroscience, Drug Discovery Sciences & Externalizations, Center for External Innovation, Takeda Development Center Americas, Inc.
Daniel Lee
Partner, PJT Partners
Jay Olson
Managing Director & Senior Analyst, Oppenheimer & Co. Inc.
Murali Gopalakrishnan
Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie, Inc.
Sahil Kirpekar
Managing Partner, Lumina Life Sciences
Sumant Kulkarni
Managing Director, Biotechnology Equity Research, Canaccord Genuity LLC
Bruce Leuchter
President & CEO, Neurvati Neurosciences, Inc.
Catherine Abbadie
Global Head S&E, Simcere Pharmaceutical Group
Charles Stacey
President & CEO, Cerecin Inc.
Christian Thomsen
Global Head, CNS BD&L, Boehringer Ingelheim International GmbH
David Stamler
CEO, Alterity Therapeutics
Guy Seabrook
Vice President & Global Lead, Neuroscience External Innovation, Johnson & Johnson Innovation LLC
John Alam
Founder & CEO, CervoMed Inc.
Lisa Ricciardi
President & CEO, Cognition Therapeutics, Inc.
Meredith Fisher
Partner, Mass General Brigham Ventures
Peter Louwagie
SVP Corporate & Business Development, Genmab A/S
Peter Thompson
General Partner,
Richard Godfrey
CEO, IRLAB Therapeutics AB